C. Ellen Jackson

1.7k total citations
18 papers, 1.4k citations indexed

About

C. Ellen Jackson is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, C. Ellen Jackson has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Hematology and 5 papers in Oncology. Recurrent topics in C. Ellen Jackson's work include Acute Myeloid Leukemia Research (6 papers), Photosynthetic Processes and Mechanisms (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). C. Ellen Jackson is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Photosynthetic Processes and Mechanisms (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). C. Ellen Jackson collaborates with scholars based in United States, United Kingdom and Slovakia. C. Ellen Jackson's co-authors include Michael Andreeff, Marina Konopleva, Anthony L. Moore, Jane E. Dench, Mark F. Munsell, Elihu H. Estey, David O. Hall, Steven M. Kornblau, Francis J. Giles and Karen Yee and has published in prestigious journals such as Blood, PLANT PHYSIOLOGY and Cancer.

In The Last Decade

C. Ellen Jackson

18 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Ellen Jackson United States 12 971 305 191 168 167 18 1.4k
Junko Okabe‐Kado Japan 26 1.5k 1.5× 287 0.9× 377 2.0× 177 1.1× 85 0.5× 90 2.0k
Giovanni Di Maira Italy 19 1.0k 1.1× 109 0.4× 310 1.6× 119 0.7× 54 0.3× 41 1.6k
Suning Chen China 20 949 1.0× 191 0.6× 169 0.9× 419 2.5× 41 0.2× 95 1.5k
Takayuki Funakoshi Japan 17 604 0.6× 165 0.5× 121 0.6× 66 0.4× 83 0.5× 73 1.2k
Taketoshi Sugiyama Japan 23 764 0.8× 126 0.4× 309 1.6× 388 2.3× 141 0.8× 100 1.6k
Nicola Vannini Switzerland 15 619 0.6× 151 0.5× 328 1.7× 206 1.2× 69 0.4× 29 1.3k
Yongmun Choi South Korea 15 1.3k 1.3× 67 0.2× 226 1.2× 106 0.6× 58 0.3× 34 1.7k
Donghwa Kim South Korea 19 764 0.8× 119 0.4× 313 1.6× 192 1.1× 49 0.3× 42 1.3k
Irena Misiewicz-Krzemińska Poland 22 823 0.8× 306 1.0× 181 0.9× 348 2.1× 56 0.3× 50 1.2k
Jay Mei United States 13 451 0.5× 204 0.7× 236 1.2× 139 0.8× 26 0.2× 47 808

Countries citing papers authored by C. Ellen Jackson

Since Specialization
Citations

This map shows the geographic impact of C. Ellen Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ellen Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ellen Jackson more than expected).

Fields of papers citing papers by C. Ellen Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ellen Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ellen Jackson. The network helps show where C. Ellen Jackson may publish in the future.

Co-authorship network of co-authors of C. Ellen Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ellen Jackson. A scholar is included among the top collaborators of C. Ellen Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ellen Jackson. C. Ellen Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Thongon, Natthakan, C. Ellen Jackson, Pamela Lockyer, et al.. (2019). ILF2 Antisense Oligonucleotide Therapy and a CRISPR/Cas9-Based Screening for DNA Repair Effectors Identify Synthetic Lethal Approaches Enhancing Myeloma Cells Sensitivity to DNA Damage. Blood. 134(Supplement_1). 685–685. 2 indexed citations
2.
Zeng, Zhihong, Dos D. Sarbassov, Ismael Samudio, et al.. (2016). Rapamycin derivatives reduce mTORC2 signaling and inhibitAKT activation inAML. 1 indexed citations
3.
Richard, Pascale, Karen Gaudon, Emmanuel Fournier, et al.. (2007). A synonymous CHRNE mutation responsible for an aberrant splicing leading to congenital myasthenic syndrome. Neuromuscular Disorders. 17(5). 409–414. 18 indexed citations
4.
Kornblau, Steven M., Deborah E. Banker, Derek L. Stirewalt, et al.. (2006). Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study. Blood. 109(7). 2999–3006. 103 indexed citations
5.
Zeng, Zhihong, Dos D. Sarbassov, Ismael Samudio, et al.. (2006). Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood. 109(8). 3509–3512. 292 indexed citations
6.
Zeng, Zhihong, Dos D. Sarbassov, Francis J. Giles, et al.. (2006). Rapamycin Analogs Reduce mTORC2 Signaling and Inhibit AKT Activation in AML.. Blood. 108(11). 156–156. 2 indexed citations
7.
Kornblau, Steven M., Yi Hua Qiu, C. Ellen Jackson, et al.. (2006). Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood. 108(7). 2358–2365. 207 indexed citations
8.
Jabbour, Elias, Srđan Verstovšek, Francis J. Giles, et al.. (2005). 2‐Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome. Cancer. 104(3). 541–546. 22 indexed citations
9.
Kornblau, Steven M., Deborah E. Banker, Zeev Estrov, et al.. (2005). Blockade of Adaptive Defensive Changes in Cholesterol Uptake and Synthesis in AML by the Addition of Pravastatin to Idarubicin + High Dose Ara-C: A Phase I Study.. Blood. 106(11). 405–405. 1 indexed citations
10.
Monaco, Giuseppe, Marina Konopleva, Mark F. Munsell, et al.. (2004). Engraftment of Acute Myeloid Leukemia in NOD/SCID Mice Is Independent of CXCR4 and Predicts Poor Patient Survival. Stem Cells. 22(2). 188–201. 38 indexed citations
11.
Konopleva, Marina, Twee Tsao, Zeev Estrov, et al.. (2004). The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia. Cancer Research. 64(21). 7927–7935. 127 indexed citations
12.
Konopleva, Marina, Shourong Zhao, Wei Hu, et al.. (2002). The anti‐apoptotic genes Bcl‐XL and Bcl‐2 are over‐expressed and contribute to chemoresistance of non‐proliferating leukaemic CD34+ cells. British Journal of Haematology. 118(2). 521–534. 128 indexed citations
13.
Konopleva, Marina, Twee Tsao, Peter P. Ruvolo, et al.. (2002). Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood. 99(1). 326–335. 157 indexed citations
14.
Moore, Anthony L., Jane E. Dench, C. Ellen Jackson, & David O. Hall. (1980). Glycine decarboxylase activity in plant tissues measured by a rapid assay technique. FEBS Letters. 115(1). 54–58. 9 indexed citations
15.
Jackson, C. Ellen, et al.. (1979). Photorespiratory Nitrogen Cycling: Evidence for a Mitochondrial Glutamine Synthetase. Biochemical Society Transactions. 7(5). 1122–1124. 6 indexed citations
16.
Jackson, C. Ellen, Jane E. Dench, David O. Hall, & Anthony L. Moore. (1979). Separation of Mitochondria from Contaminating Subcellular Structures Utilizing Silica Sol Gradient Centrifugation. PLANT PHYSIOLOGY. 64(1). 150–153. 91 indexed citations
17.
Jackson, C. Ellen, Jane E. Dench, Anthony L. Moore, et al.. (1978). Subcellular Localisation and Identification of Superoxide Dismutase in the Leaves of Higher Plants. European Journal of Biochemistry. 91(2). 339–344. 109 indexed citations
18.
Moore, Anthony L., C. Ellen Jackson, Barry Halliwell, Jane E. Dench, & D.O. Hall. (1977). Intramitochondrial localisation of glycine decarboxylase in spinach leaves. Biochemical and Biophysical Research Communications. 78(2). 483–491. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junko Okabe‐Kado Breakdown of academic impact, for papers by Giovanni Di Maira Breakdown of academic impact, for papers by Suning Chen Breakdown of academic impact, for papers by Takayuki Funakoshi Breakdown of academic impact, for papers by Taketoshi Sugiyama Breakdown of academic impact, for papers by Nicola Vannini Breakdown of academic impact, for papers by Yongmun Choi Breakdown of academic impact, for papers by Donghwa Kim Breakdown of academic impact, for papers by Irena Misiewicz-Krzemińska Breakdown of academic impact, for papers by Jay Mei
Rankless by CCL
2026